Treatment with Dexamethasone and Monophosphoryl Lipid a Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers the Ability to Modulate CD4+T Cell Responses

Garcia-Gonzalez, P; Neira, O; Schinnerling, K; Sepulveda-Gutierrez, A; Maggy, J; Hoyos, L; Morales, R; Ubilla-Olguin, G; Mehdi, A; Nel, H; Soto, L; Pesce, B; Molina, MC; Cuchacovich, M; Larrondo, M; et. al.

Más información

Título según WOS: Treatment with Dexamethasone and Monophosphoryl Lipid a Removes Disease-Associated Transcriptional Signatures in Monocyte-Derived Dendritic Cells from Rheumatoid Arthritis Patients and Confers the Ability to Modulate CD4+T Cell Responses
Volumen: 68
Fecha de publicación: 2016
Idioma: English
Notas: ISI